HEALTHJun 7 · 13:28 UTCCBS NEWS

The promises and pitfalls of GLP-1 drugs

GLP-1 drugs, approved 20 years ago for diabetes, have helped over 30 million U.S. patients reduce weight but are associated with troubling side effects. Experts suggest potential use in treating obesity-related diseases like cancer, though patient reactions vary widely.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

GLP-1 drugstopicdiabetestopicweight losstopicobesity-related diseasestopiccancertopicTracy SmithpersonU.S.place

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 7 · 13:53 UTC
The promises and pitfalls of GLP-1 drugs
HEALTHMay 21 · 21:02 UTC
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
HEALTHMay 21 · 13:02 UTC
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk
HEALTHMay 14 · 11:00 UTC
Experimental obesity drug outperforms traditional weight-loss treatments in early research
HEALTHMay 7 · 10:11 UTC
Scientists discover why Ozempic works better for some people
HEALTHJun 6 · 13:28 UTC
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk